Adial Pharmaceuticals Inc... (ADIL)
undefined
undefined%
At close: undefined
1.03
0.95%
After-hours Jan 08, 2025, 05:46 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -7.00M -12.73M -19.42M -10.89M -8.59M -11.63M -1.14M -420.20K -817.99K
Depreciation & Amortization 564.00 60.50K 55.11K 564.00 565.00 563.00 565.00 565.00 565.00
Stock-Based Compensation 1.82M 3.37M 4.24M 2.01M 1.60M 5.37M 205.40K 153.56K 250.82K
Other Working Capital -634.79K -1.48M 1.82M 786.48K 117.64K -814.51K 11.55K -8.32K 100.29K
Other Non-Cash Items 1.07M -522.00K 1.81M 1.56M 441.76K 1.13M 102.26K 7.00 1.09K
Deferred Income Tax -1.91M -502 -94.08K -1.56M n/a 3.48M n/a n/a n/a
Change in Working Capital -794.21K -1.37M 1.46M 1.25M 208.17K -849.32K 336.37K -8.32K 100.29K
Operating Cash Flow -6.81M -11.19M -11.95M -7.63M -6.34M -2.50M -494.86K -274.38K -465.22K
Capital Expenditures 6.81M n/a -64.61K n/a n/a n/a n/a n/a n/a
Acquisitions n/a n/a 30.59K n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 1.50M n/a -0.00 -350.00K n/a n/a 35.12K n/a n/a
Investing Cash Flow 1.50M n/a -34.02K -350.00K n/a n/a 35.12K n/a n/a
Debt Repayment n/a n/a n/a n/a n/a -75.00K 350.00K 200.00K n/a
Common Stock Repurchased -1.66K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 1.86K 1.89M 450.01K 1.05M 156.25K n/a n/a n/a
Financial Cash Flow 4.13M 9.13M 13.64M 5.61M 9.25M 6.35M 390.00K 200.00K n/a
Net Cash Flow -1.17M -2.06M 1.66M -2.38M 2.91M 3.85M -69.75K -74.38K -465.22K
Free Cash Flow n/a -11.19M -12.01M -7.63M -6.34M -2.50M -494.86K -274.38K -465.22K